ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry O43520


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name AT8B1_HUMAN
Primary accession number O43520
Secondary accession number Q9BTP8
Integrated into Swiss-Prot on May 30, 2000
Sequence was last modified on May 5, 2009 (Sequence version 3)
Annotations were last modified on    June 16, 2009 (Entry version 93)
Name and origin of the protein
Protein name Probable phospholipid-transporting ATPase IC
Synonyms EC 3.6.3.1
Familial intrahepatic cholestasis type 1
ATPase class I type 8B member 1
Gene name
Name: ATP8B1
Synonyms: ATPIC, FIC1, PFIC
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA], VARIANTS PFIC1 SER-288; VAL-308; 645-ILE--ILE-699 DEL AND ARG-892, VARIANTS BRIC1 THR-661 AND 795-GLY--ARG-797 DEL, AND VARIANT THR-1152.
TISSUE=Intestine, and Liver;
DOI=10.1038/ng0398-219; PubMed=9500542 [NCBI, ExPASy, EBI, Israel, Japan]
Bull L.N., van Eijk M.J.T., Pawlikowska L., DeYoung J.A., Juijn J.A., Liao M., Klomp L.W.J., Lomri N., Berger R., Scharschmidt B.F., Knisely A.S., Houwen R.H.J., Freimer N.B.;
"A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis.";
Nat. Genet. 18:219-223(1998).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature03983; PubMed=16177791 [NCBI, ExPASy, EBI, Israel, Japan]
Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K., Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R., Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
"DNA sequence and analysis of human chromosome 18.";
Nature 437:551-555(2005).
[3]
NUCLEOTIDE SEQUENCE [MRNA] OF 388-661.
TISSUE=Colon tumor;
PubMed=9548971 [NCBI, ExPASy, EBI, Israel, Japan]
Halleck M.S., Pradhan D., Blackman C.F., Berkes C., Williamson P.L., Schlegel R.A.;
"Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs.";
Genome Res. 8:354-361(1998).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 359-1251, AND VARIANT THR-1152.
TISSUE=Uterus;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
VARIANT BRIC1 THR-661.
DOI=10.1002/hep.510290214; PubMed=9918928 [NCBI, ExPASy, EBI, Israel, Japan]
Tygstrup N., Steig B.A., Juijn J.A., Bull L.N., Houwen R.H.J.;
"Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity.";
Hepatology 29:506-508(1999).
[6]
VARIANT PFIC1 ASN-554.
DOI=10.1053/jhep.2000.20520; PubMed=11093741 [NCBI, ExPASy, EBI, Israel, Japan]
Klomp L.W.J., Bull L.N., Knisely A.S., van Der Doelen M.A., Juijn J.A., Berger R., Forget S., Nielsen I.-M., Eiberg H., Houwen R.H.J.;
"A missense mutation in FIC1 is associated with Greenland familial cholestasis.";
Hepatology 32:1337-1341(2000).
[7]
VARIANTS PFIC1 PRO-127; TYR-403; PRO-412; MET-456; HIS-500; PHE-529 DEL; LEU-535; ASN-554; THR-661; GLY-688; ARG-733; SER-853; ARG-892 AND ARG-1040, VARIANTS BRIC1 ASN-70; ASP-308; PHE-344; TYR-453; GLY-454; TRP-600; GLN-600; TRP-628; THR-661; THR-694 AND ARG-892, AND VARIANT ALA-429.
DOI=10.1002/hep.20285; PubMed=15239083 [NCBI, ExPASy, EBI, Israel, Japan]
Klomp L.W.J., Vargas J.C., van Mil S.W.C., Pawlikowska L., Strautnieks S.S., van Eijk M.J.T., Juijn J.A., Pabon-Pena C., Smith L.B., DeYoung J.A., Byrne J.A., Gombert J., van der Brugge G., Berger R., Jankowska I., Pawlowska J., Villa E., Knisely A.S., Thompson R.J., Freimer N.B., Houwen R.H.J., Bull L.N.;
"Characterization of mutations in ATP8B1 associated with hereditary cholestasis.";
Hepatology 40:27-38(2004).
[8]
VARIANTS ICP THR-45 AND GLU-203, AND VARIANT GLN-952.
DOI=10.1038/sj.ejhg.5201355; PubMed=15657619 [NCBI, ExPASy, EBI, Israel, Japan]
Painter J.N., Savander M., Ropponen A., Nupponen N., Riikonen S., Ylikorkala O., Lehesjoki A.E., Aittomaki K.;
"Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy.";
Eur. J. Hum. Genet. 13:435-439(2005).
[9]
VARIANT ICP CYS-867, AND VARIANTS ASN-70; ILE-305 AND GLN-952.
DOI=10.1136/gut.2004.058115; PubMed=15888793 [NCBI, ExPASy, EBI, Israel, Japan]
Muellenbach R., Bennett A., Tetlow N., Patel N., Hamilton G., Cheng F., Chambers J., Howard R., Taylor-Robinson S.D., Williamson C.;
"ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.";
Gut 54:829-834(2005).
[10]
VARIANTS [LARGE SCALE ANALYSIS] VAL-886 AND MET-1178.
DOI=10.1126/science.1133427; PubMed=16959974 [NCBI, ExPASy, EBI, Israel, Japan]
Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E.;
"The consensus coding sequences of human breast and colorectal cancers.";
Science 314:268-274(2006).
Comments
  • FUNCTION: May play a role in the transport of aminophospholipids from the outer to the inner leaflet of various membranes and the maintenance of asymmetric distribution of phospholipids in the canicular membrane. May have a role in transport of bile acids into the canaliculus, uptake of bile acids from intestinal contents into intestinal mucosa or both.
  • CATALYTIC ACTIVITY: ATP + H2O + phospholipid(In) = ADP + phosphate + phospholipid(Out).
  • SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
  • TISSUE SPECIFICITY: Found in most tissues except brain and skeletal muscle. Most abundant in pancreas and small intestine.
  • DISEASE: Defects in ATP8B1 are the cause of progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600]; also known as Byler disease. PFIC1 is an autosomal recessive disorder, characterized by early infancy cholestasis, that may be initially episodic but progresses to malnutrition, growth retardation and end-stage liver disease before adulthood.
  • DISEASE: Defects in ATP8B1 are the cause of benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300]; also known as Summerskill syndrome. BRIC is characterized by intermittent episodes of cholestasis without progression to liver failure. There is initial elevation of serum bile acids, followed by cholestatic jaundice which generally spontaneously resolves after periods of weeks to months. The cholestatic attacks vary in severity and duration. Patients are asymptomatic between episodes, both clinically and biochemically.
  • DISEASE: Defects in ATP8B1 can be associated with intrahepatic cholestasis of pregnancy (ICP) [MIM:147480]; also known as pregnancy-related cholestasis. ICP is a multifactorial liver disorder of pregnancy. It presents during the second or, more commonly, the third trimestre of pregnancy with intense pruritus which becomes more severe with advancing gestation and cholestasis. Cholestasis results from abnormal biliary transport from the liver into the small intestine. ICP causes fetal distress, spontaneous premature delivery and intrauterine death. ICP patients have spontaneous and progressive disappearance of cholestasis after delivery.
  • SIMILARITY: Belongs to the cation transport ATPase (P-type) family. Type IV subfamily.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=ATP8B1";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
AF038007; AAC63461.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC027097; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AF032442; AAC04328.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC003534; AAH03534.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00012851; -.
RefSeq NP_005594.1; -.
UniGene Hs.216623
3D structure databases
ModBase O43520.
PTM databases
PhosphoSite O43520; -.
Enzyme and pathway databases
BRENDA 3.6.3.1; 247.
Organism-specific databases
GeneCards GC18M053466; -.
HGNC HGNC:3706; ATP8B1.
GenAtlas ATP8B1.
MIM 147480; phenotype. [NCBI / EBI]
211600; phenotype. [NCBI / EBI]
243300; phenotype. [NCBI / EBI]
602397; gene. [NCBI / EBI]
Orphanet 65682; Benign recurrent intrahepatic cholestasis.
172; Cholestasis, progressive familial intrahepatic.
79306; Cholestasis, progressive familial intrahepatic, type 1.
69665; Intrahepatic cholestasis of pregnancy.
PharmGKB PA265; -.
Gene expression databases
ArrayExpress O43520; -.
Bgee O43520; -.
CleanEx HS_ATP8B1; -.
GermOnline ENSG00000081923; Homo sapiens.
Ontologies
GO
GO:0016324; Cellular component: apical plasma membrane (inferred from direct assay from UniProtKB).
GO:0005887; Cellular component: integral to plasma membrane (non-traceable author statement from UniProtKB).
GO:0005624; Cellular component: membrane fraction (inferred from direct assay from UniProtKB).
GO:0005524; Molecular function: ATP binding (inferred from electronic annotation from UniProtKB-KW).
GO:0015662; Molecular function: ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism (inferred from electronic annotation from InterPro).
GO:0000287; Molecular function: magnesium ion binding (inferred from electronic annotation from UniProtKB-KW).
GO:0004012; Molecular function: phospholipid-translocating ATPase activity (traceable author statement from UniProtKB).
GO:0006754; Biological process: ATP biosynthetic process (inferred from electronic annotation from InterPro).
GO:0015721; Biological process: bile acid and bile salt transport (non-traceable author statement from UniProtKB).
GO:0016481; Biological process: negative regulation of transcription (inferred from mutant phenotype from UniProtKB).
GO:0015914; Biological process: phospholipid transport (inferred from electronic annotation from InterPro).
QuickGo view.
Family and domain databases
InterPro IPR008250; ATPase_P-typ_ATPase-assoc-reg.
IPR001757; ATPase_P-typ_ion-transptr.
IPR018303; ATPase_P-typ_phosphor_site.
IPR006539; ATPase_P-typ_Plipid-transl.
Graphical view of domain structure.
PANTHER PTHR11939; ATPase_P; 1.
Pfam PF00122; E1-E2_ATPase; 1.
Pfam graphical view of domain structure.
PRINTS PR00119; CATATPASE.
TIGRFAMs TIGR01652; ATPase-Plipid; 1.
TIGR01494; ATPase_P-type; 4.
PROSITE PS00154; ATPASE_E1_E2; 1.
Proteomic databases
PRIDE O43520; -.
Genome annotation databases
Ensembl ENSG00000081923; Homo sapiens. [Contig view]
GeneID 5205; -.
KEGG hsa:5205; -.
Phylogenomic databases
HOGENOM O43520; -.
HOVERGEN O43520; -.
Other
NextBio 20132; -.
SOURCE ATP8B1; Homo sapiens.
ProtoNet O43520.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
ATP-binding; Disease mutation; Hydrolase; Intrahepatic cholestasis; Magnesium; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism; Transmembrane.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
CHAIN   1   1251  1251     Probable phospholipid-transporting ATPase IC. PRO_0000046364
TOPO_DOM   1    108  108     Cytoplasmic (Potential). 
TRANSMEM   109    130  22     Potential. 
TOPO_DOM   131    136  6     Extracellular (Potential). 
TRANSMEM   137    156  20     Potential. 
TOPO_DOM   157    340  184     Cytoplasmic (Potential). 
TRANSMEM   341    362  22     Potential. 
TOPO_DOM   363    389  27     Extracellular (Potential). 
TRANSMEM   390    411  22     Potential. 
TOPO_DOM   412    949  538     Cytoplasmic (Potential). 
TRANSMEM   950    970  21     Potential. 
TOPO_DOM   971    982  12     Extracellular (Potential). 
TRANSMEM   983   1002  20     Potential. 
TOPO_DOM   1003   1032  30     Cytoplasmic (Potential). 
TRANSMEM   1033   1054  22     Potential. 
TOPO_DOM   1055   1068  14     Extracellular (Potential). 
TRANSMEM   1069   1091  23     Potential. 
TOPO_DOM   1092   1097  6     Cytoplasmic (Potential). 
TRANSMEM   1098   1118  21     Potential. 
TOPO_DOM   1119   1138  20     Extracellular (Potential). 
TRANSMEM   1139   1163  25     Potential. 
TOPO_DOM   1164   1251  88     Cytoplasmic (Potential). 
ACT_SITE   454    454        4-aspartylphosphate intermediate (By similarity). 
METAL   893    893        Magnesium (By similarity). 
METAL   897    897        Magnesium (By similarity). 
VARIANT   45     45  1     N -> T (in ICP). VAR_043044 
VARIANT   70     70  1     D -> N (in BRIC1; compound heterozygote with Q-600; uncertain pathological significance; may be associated with ICP; dbSNP:rs34719006 [NCBI]). VAR_043045 
VARIANT   78     78  1     H -> Q (in dbSNP:rs3745079 [NCBI]). VAR_029271 
VARIANT   127    127  1     L -> P (in PFIC1). VAR_043046 
VARIANT   203    203  1     K -> E (in ICP). VAR_043047 
VARIANT   288    288  1     L -> S (in PFIC1). VAR_008809 
VARIANT   305    305  1     F -> I. VAR_043048 
VARIANT   308    308  1     G -> D (in BRIC1; dbSNP:rs28939685 [NCBI]). VAR_043049 
VARIANT   308    308  1     G -> V (in PFIC1). VAR_008810 
VARIANT   344    344  1     I -> F (in BRIC1). VAR_043050 
VARIANT   384    384  1     R -> H (in dbSNP:rs2271260 [NCBI]). VAR_043051 
VARIANT   393    393  1     I -> V (in dbSNP:rs34315917 [NCBI]). VAR_043052 
VARIANT   403    403  1     S -> Y (in PFIC1). VAR_043053 
VARIANT   412    412  1     R -> P (in PFIC1). VAR_043054 
VARIANT   429    429  1     E -> A (in dbSNP:rs34018205 [NCBI]). VAR_043055 
VARIANT   453    453  1     S -> Y (in BRIC1). VAR_043056 
VARIANT   454    454  1     D -> G (in BRIC1). VAR_043057 
VARIANT   456    456  1     T -> M (in PFIC1). VAR_043058 
VARIANT   500    500  1     Y -> H (in PFIC1). VAR_043059 
VARIANT   529    529  1     Missing (in PFIC1). VAR_043060
VARIANT   535    535  1     H -> L (in PFIC1). VAR_043061 
VARIANT   554    554  1     D -> N (in PFIC1). VAR_015423 
VARIANT   577    577  1     I -> V (in dbSNP:rs3745078 [NCBI]). VAR_029272 
VARIANT   580    580  1     S -> N (in dbSNP:rs33963153 [NCBI]). VAR_043062 
VARIANT   600    600  1     R -> Q (in BRIC1; compound heterozygote with N-70). VAR_043063 
VARIANT   600    600  1     R -> W (in BRIC1). VAR_043064 
VARIANT   628    628  1     R -> W (in BRIC1). VAR_043065 
VARIANT   645    699  55     Missing (in PFIC1). VAR_008811
VARIANT   661    661  1     I -> T (in BRIC1 and PFIC1; common mutation). VAR_008812 
VARIANT   674    674  1     M -> T (in dbSNP:rs35470719 [NCBI]). VAR_043066 
VARIANT   688    688  1     D -> G (in PFIC1). VAR_043067 
VARIANT   694    694  1     I -> T (in BRIC1). VAR_043068 
VARIANT   733    733  1     G -> R (in PFIC1). VAR_043069 
VARIANT   795    797  3     Missing (in BRIC1). VAR_008814
VARIANT   814    814  1     K -> N (in dbSNP:rs34018300 [NCBI]). VAR_043070 
VARIANT   853    853  1     F -> S (in PFIC1). VAR_043071 
VARIANT   867    867  1     R -> C (in ICP). VAR_043072 
VARIANT   886    886  1     A -> V (in a breast cancer sample; somatic mutation). VAR_036499 
VARIANT   892    892  1     G -> R (in PFIC1 and BRIC1). VAR_008813 
VARIANT   952    952  1     R -> Q (in dbSNP:rs12968116 [NCBI]). VAR_029273 
VARIANT   1040   1040  1     G -> R (in PFIC1). VAR_043073 
VARIANT   1152   1152  1     A -> T (in dbSNP:rs222581 [NCBI]). VAR_055045 
VARIANT   1178   1178  1     I -> M (in a breast cancer sample; somatic mutation). VAR_036500 
CONFLICT   1016   1016        P -> L (in Ref. 4; AAH03534). 
Sequence information
Length: 1251 AA [This is the length of the unprocessed precursor] Molecular weight: 143695 Da [This is the MW of the unprocessed precursor] CRC64: 770FEF3946CB579F [This is a checksum on the sequence]
        10         20         30         40         50         60 
MSTERDSETT FDEDSQPNDE VVPYSDDETE DELDDQGSAV EPEQNRVNRE AEENREPFRK 

        70         80         90        100        110        120 
ECTWQVKAND RKYHEQPHFM NTKFLCIKES KYANNAIKTY KYNAFTFIPM NLFEQFKRAA 

       130        140        150        160        170        180 
NLYFLALLIL QAVPQISTLA WYTTLVPLLV VLGVTAIKDL VDDVARHKMD KEINNRTCEV 

       190        200        210        220        230        240 
IKDGRFKVAK WKEIQVGDVI RLKKNDFVPA DILLLSSSEP NSLCYVETAE LDGETNLKFK 

       250        260        270        280        290        300 
MSLEITDQYL QREDTLATFD GFIECEEPNN RLDKFTGTLF WRNTSFPLDA DKILLRGCVI 

       310        320        330        340        350        360 
RNTDFCHGLV IFAGADTKIM KNSGKTRFKR TKIDYLMNYM VYTIFVVLIL LSAGLAIGHA 

       370        380        390        400        410        420 
YWEAQVGNSS WYLYDGEDDT PSYRGFLIFW GYIIVLNTMV PISLYVSVEV IRLGQSHFIN 

       430        440        450        460        470        480 
WDLQMYYAEK DTPAKARTTT LNEQLGQIHY IFSDKTGTLT QNIMTFKKCC INGQIYGDHR 

       490        500        510        520        530        540 
DASQHNHNKI EQVDFSWNTY ADGKLAFYDH YLIEQIQSGK EPEVRQFFFL LAVCHTVMVD 

       550        560        570        580        590        600 
RTDGQLNYQA ASPDEGALVN AARNFGFAFL ARTQNTITIS ELGTERTYNV LAILDFNSDR 

       610        620        630        640        650        660 
KRMSIIVRTP EGNIKLYCKG ADTVIYERLH RMNPTKQETQ DALDIFANET LRTLCLCYKE 

       670        680        690        700        710        720 
IEEKEFTEWN KKFMAASVAS TNRDEALDKV YEEIEKDLIL LGATAIEDKL QDGVPETISK 

       730        740        750        760        770        780 
LAKADIKIWV LTGDKKETAE NIGFACELLT EDTTICYGED INSLLHARME NQRNRGGVYA 

       790        800        810        820        830        840 
KFAPPVQESF FPPGGNRALI ITGSWLNEIL LEKKTKRNKI LKLKFPRTEE ERRMRTQSKR 

       850        860        870        880        890        900 
RLEAKKEQRQ KNFVDLACEC SAVICCRVTP KQKAMVVDLV KRYKKAITLA IGDGANDVNM 

       910        920        930        940        950        960 
IKTAHIGVGI SGQEGMQAVM SSDYSFAQFR YLQRLLLVHG RWSYIRMCKF LRYFFYKNFA 

       970        980        990       1000       1010       1020 
FTLVHFWYSF FNGYSAQTAY EDWFITLYNV LYTSLPVLLM GLLDQDVSDK LSLRFPGLYI 

      1030       1040       1050       1060       1070       1080 
VGQRDLLFNY KRFFVSLLHG VLTSMILFFI PLGAYLQTVG QDGEAPSDYQ SFAVTIASAL 

      1090       1100       1110       1120       1130       1140 
VITVNFQIGL DTSYWTFVNA FSIFGSIALY FGIMFDFHSA GIHVLFPSAF QFTGTASNAL 

      1150       1160       1170       1180       1190       1200 
RQPYIWLTII LAVAVCLLPV VAIRFLSMTI WPSESDKIQK HRKRLKAEEQ WQRRQQVFRR 

      1210       1220       1230       1240       1250 
GVSTRRSAYA FSHQRGYADL ISSGRSIRKK RSPLDAIVAD GTAEYRRTGD S 

O43520 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!